IGC Pharma (IGC) Proxy Filing summary

Executive summary

• Annual meeting scheduled for October 10, 2025, at 11:00 AM EST in Potomac, Maryland.

• Shareholders are encouraged to vote by October 9, 2025, either online, by mail, or in person.

Voting matters and shareholder proposals

• Election of two directors: Ram Mukunda and James Moran.

• Ratification of Manohar Chowdhry & Associates as independent auditor for fiscal year 2026.

• Approval of 5,000,000 shares under the 2018 Omnibus Incentive Plan for employees, advisors, directors, and consultants, based on performance and vesting metrics.

• Amendment to increase authorized common stock from 150,000,000 to 600,000,000 shares.

• Proposal to allow adjournment or postponement of the meeting if necessary.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals, including director elections and share authorization increase.